These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 40027)

  • 21. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential antisecretory antidiarrheals. 2. Alpha 2-adrenergic 2-[(aryloxy)alkyl]imidazolines.
    Moormann AE; Pitzele BS; Jones PH; Gullikson GW; Albin D; Yu SS; Bianchi RG; Sanguinetti EL; Rubin B; Grebner M
    J Med Chem; 1990 Feb; 33(2):614-26. PubMed ID: 1967650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
    Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
    J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-(Aminoalkyl)-7-hydroxy-2(3H)-indolones, a novel class of potent presynaptic dopamine receptor agonists.
    Huffman WF; Hall RF; Grant JA; Wilson JW; Hieble JP; Hahn RA
    J Med Chem; 1983 Jul; 26(7):933-5. PubMed ID: 6306238
    [No Abstract]   [Full Text] [Related]  

  • 25. N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist.
    Kohli JD; Goldberg LI; Volkman PH; Cannon JG
    J Pharmacol Exp Ther; 1978 Oct; 207(1):16-22. PubMed ID: 702336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. , '- and , '-deuterium-labeled dopamine. Synthesis and pharmacologic actions.
    Perel JM; Dawson DK; Dayton PG; Goldberg LI
    J Med Chem; 1972 Jul; 15(7):714-6. PubMed ID: 5043869
    [No Abstract]   [Full Text] [Related]  

  • 27. Congeners of the alpha conformer of dopamine derived from octahydrobenz[h]isoquinoline.
    Cannon JG; Lee T; Hsu FL; Long JP; Flynn JR
    J Med Chem; 1980 May; 23(5):502-5. PubMed ID: 7381848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic agonists: comparative actions of amine and sulfonium analogues of dopamine.
    Hamada A; Chang YA; Uretsky N; Miller DD
    J Med Chem; 1984 May; 27(5):675-80. PubMed ID: 6143827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of 2-(alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines and evaluation as potential dopamine agonists.
    Grosso JA; Nichols DE; Kohli JD; Glock D
    J Med Chem; 1982 Jun; 25(6):703-8. PubMed ID: 7097723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
    Pfeiffer FR; Wilson JW; Weinstock J; Kuo GY; Chambers PA; Holden KG; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM
    J Med Chem; 1982 Apr; 25(4):352-8. PubMed ID: 7069713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors.
    Kohli JD; Weder AB; Goldberg LI; Ginos JZ
    J Pharmacol Exp Ther; 1980 May; 213(2):370-4. PubMed ID: 7365696
    [No Abstract]   [Full Text] [Related]  

  • 32. N-Alkyl derivatives of (+/-)-alpha-methyldopamine.
    Cannon JG; Perez Z; Long JP; Rusterholz DB; Flynn JR; Costall B; Fortune DH; Naylor RJ
    J Med Chem; 1979 Aug; 22(8):901-7. PubMed ID: 573798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal effects of dopamine and dopexamine in the newborn anesthetized rabbit.
    Jaton T; Thonney M; Gouyon JB; Guignard JP
    Life Sci; 1992; 50(3):195-202. PubMed ID: 1346227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-adrenergic activity of N,N-dimethyldopamine (DMDA).
    Kitzen JM; Ilhan M; Cannon JG; Long JP
    Eur J Pharmacol; 1976 Aug; 38(2):365-72. PubMed ID: 8321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational requirements of alpha 2-adrenergic receptors.
    Ruffolo RR; Anderson KS; Miller DD
    Mol Pharmacol; 1982 Mar; 21(2):259-61. PubMed ID: 6285164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of dopexamine HCl upon collateral perfusion of the acutely ischemic myocardium in anesthetized dogs.
    Gosselin AM; Biro GP
    Angiology; 1990 Dec; 41(12):1058-64. PubMed ID: 1980579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine.
    Kaiser C; Dandridge PA; Garvey E; Hahn RA; Sarau HM; Setler PE; Bass LS; Clardy J
    J Med Chem; 1982 Jun; 25(6):697-703. PubMed ID: 6980283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride).
    Smith GW; O'Connor SE
    Am J Cardiol; 1988 Aug; 62(5):9C-17C. PubMed ID: 2900602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the cardiovascular actions of dopamine and epinine in the dog.
    Itoh H; Kohli JD; Rajfer SI; Goldberg LI
    J Pharmacol Exp Ther; 1985 Apr; 233(1):87-93. PubMed ID: 2858584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.